OpenNashEarnings

Software · NYSE: VEEV

Veeva Systems earnings: results, call transcripts & KPI history

2 quarters · fiscal year ends January · next results expected around 19 Nov 2026

Investor relations ↗SEC filings ↗KPIs as CSV

Latest: Q2 FY2027

Veeva's Vault CRM had its best quarter ever, with 12 top 20 biopharma commitments, while Veeva Falcon agentic AI for clinical, regulatory and safety moves toward first go-lives.

Veeva's push into AI-driven applications gained traction. Vault CRM has more than 180 customers live, including five top 20 biopharmas, and a top 20 biopharma rolled out Vault CRM with the Agentic Call Report to its full U.S. field team. Development Cloud and Quality Cloud saw broad adoption: a large biopharma selected Veeva EDC, Veeva Safety passed 100 customers, and Quality added more than 30 new customers. Veeva also acquired Copli and launched Veeva Falcon MLR.

Read the Q2 FY2027 summary →Q2 FY2027 slides (PDF) ↗

Quarters

KPI history

Revenue$928.0M+17.6% y/yQ2 FY27
Q3 FY25: $699.2MQ3 25$699.2MQ4 FY25: $720.9M (worked out from the annual figure)Q4 25$720.9MQ1 FY26: $759.0MQ1 26$759.0MQ2 FY26: $789.1MQ2 26$789.1MQ3 FY26: $811.2MQ3 26$811.2MQ4 FY26: $836.0M (worked out from the annual figure)Q4 26$836.0MQ1 FY27: $882.9MQ1 27$882.9MQ2 FY27: $928.0MQ2 27$928.0M

Fourth quarter worked out from the annual figure.

Data
Q3 FY25$699.2M
Q4 FY25$720.9M *
Q1 FY26$759.0M
Q2 FY26$789.1M
Q3 FY26$811.2M
Q4 FY26$836.0M *
Q1 FY27$882.9M
Q2 FY27$928.0M
Diluted EPS (GAAP)$1.66+39.5% y/yQ2 FY27
Q3 FY25: $1.13Q3 25$1.13Q1 FY26: $1.37Q1 26$1.37Q2 FY26: $1.19Q2 26$1.19Q3 FY26: $1.40Q3 26$1.40Q1 FY27: $1.57Q1 27$1.57Q2 FY27: $1.66Q2 27$1.66
Data
Q3 FY25$1.13
Q1 FY26$1.37
Q2 FY26$1.19
Q3 FY26$1.40
Q1 FY27$1.57
Q2 FY27$1.66

Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.

Operating margin29.6%+4.8 pts y/yQ2 FY27
Q3 FY25: 25.9%Q3 2525.9%Q4 FY25: 26.1%Q4 2526.1%Q1 FY26: 30.8%Q1 2630.8%Q2 FY26: 24.8%Q2 2624.8%Q3 FY26: 29.7%Q3 2629.7%Q4 FY26: 29.4%Q4 2629.4%Q1 FY27: 30.9%Q1 2730.9%Q2 FY27: 29.6%Q2 2729.6%
Data
Q3 FY2525.9%
Q4 FY2526.1%
Q1 FY2630.8%
Q2 FY2624.8%
Q3 FY2629.7%
Q4 FY2629.4%
Q1 FY2730.9%
Q2 FY2729.6%
Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue$699.2M$720.9Md$759.0M$789.1M$811.2M$836.0Md$882.9M$928.0M
Gross margin75.1%74.9%77.1%75.3%75.4%74.5%75.0%75.0%
Operating income$181.4M$188.4Md$233.7M$195.9M$240.9M$245.9Md$273.1M$275.0M
Operating margin25.9%26.1%30.8%24.8%29.7%29.4%30.9%29.6%
Net income$185.8M$195.6Md$228.2M$200.3M$236.2M$244.2Md$260.9M$273.4M
Diluted EPS$1.13—$1.37$1.19$1.40—$1.57$1.66
Operating cash flow$164.1Md$69.5Md$877.2M$238.4Md$192.8Md$106.8Md$1.1B$238.7Md
R&D expense$172.4M$181.5Md$184.0M$192.7M$191.9M$198.8Md$208.3M$222.9M

From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.

10-K and 10-Q filings